Herpes zoster in Australia: Evidence of increase in incidence in adults attributable to varicella immunization?

Epidemiology and Infection

Volumn 139, Issue 5, 2011, Pages 658-665

  Jardine, A ^a,b   Conaty, S J ^a   Vally, H ^b  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b The Australian National University   (Australia)

Author keywords

Vaccination (immunization); varicella zoster; zoster (shingles)

Indexed keywords

CHICKENPOX VACCINE; ANTIVIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; CHICKENPOX; CLINICAL FEATURE; CONTROLLED STUDY; FUNDING; GEOGRAPHIC DISTRIBUTION; HERPES ZOSTER; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRESCRIPTION; TREND STUDY; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS IDENTIFICATION; AGED; DRUG UTILIZATION; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; STATISTICS; UTILIZATION REVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; AUSTRALIA; CHICKENPOX VACCINE; DRUG UTILIZATION; HERPES ZOSTER; HOSPITALIZATION; HUMANS; IMMUNIZATION; INCIDENCE; MIDDLE AGED; YOUNG ADULT;

EID: 79957735502     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268810001949     Document Type: Article

References (38)

1. Stein AN, et al. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 2009; 27: 520-529.
2. MacIntyre CR, et al. Use of hospitalization and pharmaceutical prescribing data to compare the prevaccination burden of varicella and herpes zoster in Australia. Epidemiology and Infection 2003; 131: 675-682. (Pubitemid 37062889)
3. Carapetis JR, et al. The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 2004; 23: 755-761. (Pubitemid 39473173)
4. Brotherton J, et al. Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002. Communicable Diseases Intelligence 2004; 28 (Suppl. 2) : vii-S116.
5. Vally H, et al. An outbreak of chickenpox at a child care centre in Western Australia. Costs to the community and implications for vaccination policy. Australian and New Zealand Journal of Public Health 2007; 31: 113-119. (Pubitemid 46629498)
6. Chant KG, et al. Varicella-zoster virus infection in Australia. Australian and New Zealand Journal of Public Health 1998; 22: 413-418. (Pubitemid 28339678)
7. Nguyen HQ, et al. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 2005; 352: 450-458. (Pubitemid 40175971)
8. Zhou F, et al. Impact of varicella vaccination on health care utilization. Journal of the American Medical Association 2005; 294: 797-802. (Pubitemid 41175722)
9. Seward JF, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. Journal of the American Medical Association 2002; 287: 606-611. (Pubitemid 34252012)
10. Davis MM, et al. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 2004; 114: 786-792. (Pubitemid 41529540)
11. Jumaan AO, et al. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. Journal of Infectious Diseases 2005; 191: 2002-2007. (Pubitemid 40800569)
12. Hope-Simpson RE. Nature of herpes zoster - a longterm study and a new hypothesis. Proceedings of the Royal Society of Medicine 1965; 58: 9-20.
13. Brisson M, et al. Exposure to varicella boosts immunity to herpes-zoster : implications for mass vaccination against chickenpox. Vaccine 2002; 20: 2500-2507. (Pubitemid 34615588)
14. Solomon BA, et al. Lasting immunity to varicella in doctors study (L.I.V.I.D. study). Journal of the American Academy of Dermatology 1998; 38: 763-765. (Pubitemid 28213723)
15. Thomas SL, et al. Contacts with varicella or with children and protection against herpes zoster in adults : a case-control study. Lancet 2002; 360: 678-682. (Pubitemid 35232336)
16. Brisson M, et al. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiology and Infection 2000; 125: 651-669. (Pubitemid 32156853)
17. Brisson M, et al. Varicella vaccination : impact of vaccine efficacy on the epidemiology of VZV. Journal of Medical Virology 2003; 70(Suppl. 1) : S31-S37. (Pubitemid 36368842)
18. Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bulletin of Mathematical Biology 1999; 61: 1031-1064.
19. Garnett GP, Grenfell BT. The epidemiology of varicella-zoster virus infections : the influence of varicella on the prevalence of herpes zoster. Epidemiology and Infection 1992; 108: 513-528.
20. Mullooly JP, et al. Incidence of herpes zoster, 1997-2002. Epidemiology and Infection 2005; 133: 245-253.
21. Yih WK, et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5: 68.
22. Yawn BP, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clinic Proceedings 2007; 82: 1341-1349. (Pubitemid 350060129)
23. Patel MS, et al. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infection Control and Hospital Epidemiology 2008; 29: 1157-1163.
24. Civen R, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatric Infectious Disease Journal 2009; 28: 954-959.
25. Gidding HF, et al. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Australian and New Zealand Journal of Public Health 2005; 29: 544-551. (Pubitemid 41782611)
26. Gao Z, et al. Modelling the impact of one-dose vs. two-dose vaccination regimens on the epidemiology of varicella zoster virus in Australia. Epidemiology and Infection 2010; 138: 457-468.
27. Oxman MN, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. New England Journal of Medicine 2005; 352: 2271-2284.
28. Cunningham AL, et al. The prevention and management of herpes zoster. Medical Journal of Australia 2008; 188: 171-176.
29. Garnett GP, Ferguson NM. Predicting the effect of varicella caccine on subsequent cases of zoster and varicella. Reviews in Medical Virology 1996; 6: 151-161. (Pubitemid 26297192)
30. Australian Bureau of Statistics. Population by age and sex, Australian states and territories, JunE 2008. Canberra, 2008.
31. Hull B, et al. Immunisation coverage annual report, 2007. Communicable Diseases Intelligence 2009; 33: 170-187.
32. Macartney KK, et al. Varicella vaccination in Australia. Journal of Paediatrics and Child Health 2005; 41: 544-552.
33. Gilbert GL, et al. Varicella seroprevalence and vaccine uptake in preschool children. Medical Journal of Australia 2005; 182: 42. (Pubitemid 40089877)
34. Marshall H, et al. Uptake of varicella vaccine - a cross sectional survey of parental attitudes to nationally recommended but unfunded varicella immunisation. Vaccine 2005; 23: 5389-5397. (Pubitemid 41579310)
35. Marshall H, et al. Varicella immunisation practice : Implications for provision of a recommended, nonfunded vaccine. Journal of Paediatrics and Child Health 2009; 45: 297-303.
36. Miller ER, Kelly HA. Varicella infection - evidence for peak activity in summer months. Journal of Infection 2008; 56: 360-365.
37. Zak-Prelich M, et al. The role of solar ultraviolet irradiation in zoster. Epidemiology and Infection 2002; 129: 593-597. (Pubitemid 36157684)
38. Thomas SL, Hall AJ. What does epidemiology tell us about risk factors for herpes zoster ? Lancet Infectious Diseases 2004; 4: 26-33. (Pubitemid 38057055)